Rifampin reduces oral morphine absorption: A case of transdermal buprenorphine selection based on morphine pharmacokinetics

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 26, Issue 4, 2012, Pages 362-367

  Fudin, Jeffrey ^a,b   Fontenelle, Dania Vanesta ^b   Payne, Annette ^a  

^a STRATTON VA MEDICAL CENTER   (United States)

^b ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

Buprenorphine; Interaction; Morphine; P glycoprotein; Pseudoaddiction; Rifampin; Serum analysis

Indexed keywords

BUPIVACAINE; BUPRENORPHINE; CLONIDINE; ENOXAPARIN; FENTANYL; GENTAMICIN; HYDROMORPHONE; MORPHINE; MORPHINE SULFATE; MULTIDRUG RESISTANCE PROTEIN; NYSTATIN; OMEPRAZOLE; OXACILLIN; OXYCODONE; OXYCODONE PLUS PARACETAMOL; PROBIOTIC AGENT; RIFAMPICIN; TRAMADOL; TRIAMCINOLONE; VANCOMYCIN; WARFARIN;

ADULT; ALCOHOLISM; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; CASE REPORT; CHRONIC PAIN; COMPRESSION FRACTURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EVENING DOSAGE; FRACTURE FIXATION; HEADACHE; HEROIN DEPENDENCE; HUMAN; INTENSIVE CARE; LOW BACK PAIN; MALE; MEDICAL HISTORY; MORNING DOSAGE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCUPATIONAL ACCIDENT; PAIN; PATIENT SATISFACTION; SPINE FRACTURE; SPINE STABILIZATION; VISUAL ANALOG SCALE;

ADMINISTRATION, ORAL; ANALGESICS, OPIOID; ANTIBIOTICS, ANTITUBERCULAR; BUPRENORPHINE; DRUG INTERACTIONS; HOSPITALS, VETERANS; HUMANS; MALE; MIDDLE AGED; MORPHINE; P-GLYCOPROTEIN; RIFAMPIN; TRANSDERMAL PATCH;

EID: 84870942635     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.3109/15360288.2012.734903     Document Type: Article

References (15)

1. Fudin J. Opioid pharmacokinetics and expected metabolites. 2011. Available at: Http://paindr.com/wp-content/uploads/ 2012/05/Opioid-Serum- Predictability-and-Metabolites.pdf. Accessed August 27, 2012
2. Pharmacist's letter. Drug interactions. 2012. Available at: Http://pharmacistsletter.therapeut icresearch.com/pl/ ArticleDD.aspx?nidchk= 1&cs=STUDENT&s=PL&pt=6& fpt=31&dd=260603&pb= PL&searchid=36715122. Accessed August 24, 2012
3. Baumann TJ, Strickland JM, Herndon CM. Pain management. In: Talbert RL, DiPiro JT, Matzke GR, Posey LM, Wells BG, Yee GC, eds. Pharmacotherapy: A Pathophysiologic Approach. 8th ed. New York: McGraw-Hill; 2011: 989-1003 Interaction: Morphine, Rifampin. In: LexiComp Online [database on the Internet]
4. Hudson, OH: Lexi-Comp, Inc.; 2012. Available at: Http://online.lexi.com/ lco/action/interact. Accessed September 12, 2012. [Subscription required to view.]
5. Interaction: Morphine, Rifampin. In: Micromedex Online [database on the Internet]. Greenwood Village, CO: Thompson Micromedex; 1974-2012. Available at: Www.micromedex.com. Accessed September 12, 2012. [Subscription required to view.]
6. Fromm MF, Eckhardt K, Li S, et al. Loss of analgesic effect of morphine due to coadministration of rifampin. Pain. 1997;72:261-267 (Pubitemid 27321925)
7. Cavallari LH, Lam YW. Pharmacogenetics. In: Talbert RL, DiPiro JT, Matzke GR, Posey LM, Wells BG, Yee GC, eds. Pharmacotherapy: A Pathophysiologic Approach. 8th ed.; 2011. Available at: Http://www.accesspharmacy.com/ content.aspx?aID=7966967. Accessed August 24, 2012
8. Kharasch ED, Hoffer C, Whittington D, Sheffels P. Role of Pglycoprotein in the intestinal absorption and clinical effects of morphine. Clin Pharmacol Ther. 2003;74:543-554 (Pubitemid 37521998)
9. Greiner B, Eichelbaum M, Fritz P, Kreichgauer HP. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest. 1999;104:147-153
10. Coluzzi F., Pappagallo M. Opioid therapy for chronic non cancer pain: Practice guidelines for initiation and maintenance of therapy. Minerva Anestesiol. 2005;425-433 (Pubitemid 43932967)
11. Weissman DE, Haddox JD. Opioid pseudoaddiction - an iatrogenic syndrome. Pain. 1989;36:363-366 (Pubitemid 19077936)
12. Fudin J, Levasseur DJ, Passik SD, Kirsh KL, Coleman J. Chronic pain management with opioids in patients with past or current substance abuse problems. J Pharm Pract. 2003;16:291-308 Butrans: Buprenorphine Transdermal Patch [package insert]. (Pubitemid 37236586)
13. Stamford, CT: Purdue Pharma; 2010 Pharmacist's Letter. Cytochrome P450 interactions. 2012 Available at: Http://pharmacistsletter.therapeuticresearch. com/pl/ArticleDD.aspx?nidchk=1&cs=PLPHONLY NDALL LI&s=PL&pt= 6&fpt=31&dd=260112&pb=PL&cat=4302 Accessed August 24, 2012
14. Donnelly S, Davis MP, Walsh D. World Health Organization. Morphine in cancer pain management: A practical guide. Support Care Cancer. 2002;10:13-35 (Pubitemid 36055881)
15. Jasinski DR, Pevnick JS, Griffith JD. Human pharmacology and abuse potential of the analgesic buprenorphine: A potential agent for treating narcotic addiction. Arch Gen Psychiatr. 1978;35:501-516. (Pubitemid 8337042)